Susquehanna International Group’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6K | Buy |
+2,459
| New | +$13.6K | ﹤0.01% | 6181 |
|
|
2025
Q1 | – | Sell |
-4,016
| Closed | -$37.2K | – | 6894 |
|
|
2024
Q4 | $37.2K | Buy |
+4,016
| New | +$37.2K | ﹤0.01% | 5924 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6307 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6284 |
|
|
2023
Q4 | – | Sell |
-1,091
| Closed | -$16.9K | – | 6425 |
|
|
2023
Q3 | $16.9K | Sell |
1,091
-2,182
| -67% | -$33.8K | ﹤0.01% | 5289 |
|
|
2023
Q2 | $70.7K | Buy |
3,273
+922
| +39% | +$19.9K | ﹤0.01% | 5126 |
|
|
2023
Q1 | $41.8K | Sell |
2,351
-1,645
| -41% | -$29.2K | ﹤0.01% | 5466 |
|
|
2022
Q4 | $67.6K | Buy |
+3,996
| New | +$67.6K | ﹤0.01% | 5086 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6664 |
|
|
2022
Q2 | – | Sell |
-9,251
| Closed | -$540K | – | 6404 |
|
|
2022
Q1 | $540K | Buy |
9,251
+1,725
| +23% | +$101K | ﹤0.01% | 3616 |
|
|
2021
Q4 | $542K | Buy |
7,526
+2,534
| +51% | +$182K | ﹤0.01% | 3675 |
|
|
2021
Q3 | $404K | Buy |
+4,992
| New | +$404K | ﹤0.01% | 3963 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5727 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5576 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5144 |
|
|
2020
Q3 | – | Sell |
-1,930
| Closed | -$497K | – | 4810 |
|
|
2020
Q2 | $497K | Buy |
1,930
+1,170
| +154% | +$301K | ﹤0.01% | 2937 |
|
|
2020
Q1 | $338K | Buy |
760
+113
| +17% | +$50.3K | ﹤0.01% | 3302 |
|
|
2019
Q4 | $437K | Buy |
+647
| New | +$437K | ﹤0.01% | 2798 |
|